Tella Inc
TSE:2191

Watchlist Manager
Tella Inc Logo
Tella Inc
TSE:2191
Watchlist
Price: 2 JPY -50% Market Closed
Market Cap: 101.3m JPY

Operating Margin

-1 028.8%
Current
No historical data
Comparison unavailable

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-1 028.8%
=
Operating Income
¥-919.3m
/
Revenue
¥89.4m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-1 028.8%
=
Operating Income
¥-919.3m
/
Revenue
¥89.4m

Peer Comparison

Country Company Market Cap Operating
Margin
JP
Tella Inc
TSE:2191
101.3m JPY
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
241.7B USD
Loading...
US
Danaher Corp
NYSE:DHR
170.5B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
38.3B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
41.1B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
279.2B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
39.6B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
29.5B USD
Loading...
US
Waters Corp
NYSE:WAT
23.8B USD
Loading...
No Stocks Found

Market Distribution

Lower than 99% of companies in Japan
Percentile
1st
Based on 6 730 companies
1st percentile
-1 028.8%
Low
-125 500% — 4.2%
Typical Range
4.2% — 10.6%
High
10.6% — 9 743.7%
Distribution Statistics
Japan
Min -125 500%
30th Percentile 4.2%
Median 7%
70th Percentile 10.6%
Max 9 743.7%

Tella Inc
Glance View

tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. The company is headquartered in Shinjuku, Tokyo-To and currently employs 30 full-time employees. The company went IPO on 2009-03-26. The firm operates through three business segments. The Cell Medicine segment is engaged in the provision of cancer treatment technology and operational method centered on dendritic cell vaccine therapy. This segment is also engaged in the provision of Services for contract medical institutions, such as cell culture system maintenance support services, management system maintenance support services and disease support services. The Medical Support segment is mainly engaged in the provision of drug development services (CROs) and genetic testing services. The Pharmaceutical segment is engaged in the development of the dendritic cell vaccine for regulatory approval as a product for cancer regenerative medicine.

Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-1 028.8%
=
Operating Income
¥-919.3m
/
Revenue
¥89.4m
How has Operating Margin changed over time?

Over the last 3 years, Tella Inc’s Operating Margin has decreased from -143.1% to -1 028.8%. During this period, it reached a low of -1 551% on Mar 31, 2021 and a high of -134% on Jun 30, 2019.

Back to Top